These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 9720262)

  • 41. Prion channel proteins and their role in vacuolation and neurodegenerative diseases.
    Kourie JI
    Eur Biophys J; 2002 Sep; 31(5):409-16. PubMed ID: 12202918
    [TBL] [Abstract][Full Text] [Related]  

  • 42. On safari with PrP: prion diseases of animals.
    Westaway D; Carlson GA; Prusiner SB
    Trends Microbiol; 1995 Apr; 3(4):141-7. PubMed ID: 7613755
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Shrinking prions: new folds to old questions.
    Aguzzi A; Brandner S
    Nat Med; 1999 May; 5(5):486-7. PubMed ID: 10229220
    [No Abstract]   [Full Text] [Related]  

  • 44. PrPc does not mediate internalization of PrPSc but is required at an early stage for de novo prion infection of Rov cells.
    Paquet S; Daude N; Courageot MP; Chapuis J; Laude H; Vilette D
    J Virol; 2007 Oct; 81(19):10786-91. PubMed ID: 17626095
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A receptor for infectious and cellular prion protein.
    Martins VR
    Braz J Med Biol Res; 1999 Jul; 32(7):853-9. PubMed ID: 10454744
    [TBL] [Abstract][Full Text] [Related]  

  • 46. KDEL-tagged anti-prion intrabodies impair PrP lysosomal degradation and inhibit scrapie infectivity.
    Vetrugno V; Cardinale A; Filesi I; Mattei S; Sy MS; Pocchiari M; Biocca S
    Biochem Biophys Res Commun; 2005 Dec; 338(4):1791-7. PubMed ID: 16288721
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Towards further reduction and replacement of animal bioassays in prion research by cell and protein misfolding cyclic amplification assays.
    Boerner S; Wagenführ K; Daus ML; Thomzig A; Beekes M
    Lab Anim; 2013 Apr; 47(2):106-15. PubMed ID: 23479773
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Efficient interspecies transmission of synthetic prions.
    Block AJ; Shikiya RA; Eckland TE; Kincaid AE; Walters RW; Ma J; Bartz JC
    PLoS Pathog; 2021 Jul; 17(7):e1009765. PubMed ID: 34260664
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Photo-induced crosslinking of prion protein oligomers and prions.
    Piening N; Weber P; Högen T; Beekes M; Kretzschmar H; Giese A
    Amyloid; 2006 Jun; 13(2):67-77. PubMed ID: 16911960
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Prion protein and copper: a mysterious relationship].
    Rachidi W; Riondel J; McMahon HM; Favier A
    Pathol Biol (Paris); 2005 May; 53(4):244-50. PubMed ID: 15850959
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Conformational transitions in peptides containing two putative alpha-helices of the prion protein.
    Zhang H; Kaneko K; Nguyen JT; Livshits TL; Baldwin MA; Cohen FE; James TL; Prusiner SB
    J Mol Biol; 1995 Jul; 250(4):514-26. PubMed ID: 7542350
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Full restoration of specific infectivity and strain properties from pure mammalian prion protein.
    Burke CM; Walsh DJ; Steele AD; Agrimi U; Di Bari MA; Watts JC; Supattapone S
    PLoS Pathog; 2019 Mar; 15(3):e1007662. PubMed ID: 30908557
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prions: a model of conformational disease?
    Morinet F
    Pathol Biol (Paris); 2014 Apr; 62(2):96-9. PubMed ID: 24656441
    [TBL] [Abstract][Full Text] [Related]  

  • 54. PrP interactions with nucleic acids and glycosaminoglycans in function and disease.
    Silva JL; Gomes MP; Vieira TC; Cordeiro Y
    Front Biosci (Landmark Ed); 2010 Jan; 15(1):132-50. PubMed ID: 20036811
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Unfolding chaperone as a prion protein relating molecule].
    Hachiya NS; Sakasegawa Y; Kaneko K
    Rinsho Shinkeigaku; 2003 Nov; 43(11):817-9. PubMed ID: 15152473
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Some implications of the prion paradigm: caveat denaturor.
    Lederberg J
    JAMA; 1999 Oct; 282(14):1332-3. PubMed ID: 10527177
    [No Abstract]   [Full Text] [Related]  

  • 57. Theoretical studies of sequence effects on the conformational properties of a fragment of the prion protein: implications for scrapie formation.
    Kazmirski SL; Alonso DO; Cohen FE; Prusiner SB; Daggett V
    Chem Biol; 1995 May; 2(5):305-15. PubMed ID: 9383432
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Normal host prion protein necessary for scrapie-induced neurotoxicity.
    Brandner S; Isenmann S; Raeber A; Fischer M; Sailer A; Kobayashi Y; Marino S; Weissmann C; Aguzzi A
    Nature; 1996 Jan; 379(6563):339-43. PubMed ID: 8552188
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prion protein diversity and disease in the transmissible spongiform encephalopathies.
    Priola SA
    Adv Protein Chem; 2001; 57():1-27. PubMed ID: 11447687
    [No Abstract]   [Full Text] [Related]  

  • 60. Prion diseases and the central dogma of molecular biology.
    Hunter N
    Trends Microbiol; 1999 Jul; 7(7):265-6. PubMed ID: 10390630
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.